Blockade of telomerase function in various cells

Anti-Cancer Drug Design

Volumn 14, Issue 4, 1999, Pages 305-316

  Yegorov, Yegor E ^a   Akimov, Sergei S ^a   Akhmalisheva, Aliya K ^a   Semenova, Irina V ^a   Smirnova, Yuliya B ^a   Kraevsky, Alexander A ^a   Zelenin, Alexander V ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Cancer; Crisis; Differentiation; Reverse transcriptase; Senescence; Spontaneous transformation; Telomerase inhibitors; Telomeres

Indexed keywords

CARBOVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TELOMERASE; ZALCITABINE; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; DRUG ACTIVITY; EMBRYO; ENZYME INHIBITION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; SENESCENCE;

3T3 CELLS; ANIMALS; CELL AGING; CELL DIFFERENTIATION; CELL DIVISION; ENZYME INHIBITORS; HUMANS; MICE; MICE, INBRED CBA; MITOSIS; RATS; TELOMERASE;

EID: 0032741722     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D. (1989) Molecular Biology of the Cell. Garland Publishing: New York.
2. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proceedings of the National Academy of Sciences, USA, 89, 10114.
3. Allsopp R.C., Chang E., Kashefi-Aazam M., Rogaev E.I., Platyszek M.A., Shay J.W., Harley C.B. (1995) Telomere shortening is associated with cell division in vitro and in vivo. Experimental Cell Research, 220, 194.
4. Bednenko J., Melek M., Greene E.C., Shippen D.E. (1997) Developmentally regulated initiation of DNA synthesis by telomerase: evidence for factor-assisted de novo telomere formation. EMBO Journal, 16, 2507.
5. Blackburn E.H. (1991) Structure and function of telomeres. Nature, 350, 569.
6. Blasco M.A., Lee H.-W., Hande M.P., Samper E., Lansdorp P.M., Deplnho R.A., Greider C.W. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91, 25.
7. Chernov D.N., Yegorov Y.E., Akimov S.S. (1996) Telomerase activity of mouse cells as a result of spontaneous transformation. Doklady Biochemistry, 349, 55.
8. Cohn M., Blackburn E.H. (1995) Telomerase in yeast. Science, 269, 396.
9. Collins K., Greider C.W. (1993) Tetrahymena telomerase catalyzes nucleolytic cleavage and nonprocessive elongation. Genes and Development, 7, 1364.
10. Counter C.M., Avilion A.A., Lefeuvre C., Stewart N.G., Greider C.W., Harley C.B., Bacchetti S. (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO Journal, 11, 1921.
11. Curatolo L., Erba F., Morasca L. (1984) Culture conditions induce the appearance of immortalized C3H mouse cell lines. In Vitro, 20, 597.
12. Feng J., Funk W.D., Wang, S.-S., Weinrich S.L., Avilion A.A., Chiu C.-P., Adams R.R., Chang E., Allsopp R.C., Yu J. Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., Villeponteau B. (1995) The RNA component of human telomerase. Science, 269, 1236.
13. Gomez D.E., Tejera A.M., Olivero O.A. (1998) Irreversible telomere shortening by 3′-azido-2′,3′-dideoxythymidine (AZT) treatment. Biochemical and Biophysical Research Communications, 246, 107.
14. Greider C.W., Blackburn F. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43, 405.
15. Greider C.W., Blackburn E.H. (1989) A telomeric sequence in RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature, 337, 331.
16. Hara E., Tsurui H., Shinozaki A., Nakada S., Oda K. (1991) Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochemical and Biophysical Research Communications, 179, 528.
17. Harley C.B. (1991) Telomere loss: mitotic clock or genetic time bomb? Mutation Research, 256, 271.
18. Harley C.B., Futcher A.B., Greider C.W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature, 345, 458.
19. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. (1990) Telomere reduction in human colorectal carcinoma and with ageing. Nature, 346, 866.
20. Holt S.F., Aisner D.L., Shay J.W., Wright W.E. (1997) Lack of cell cycle regulation of telomerase activity in human cells. Proceedings of the National Academy of Sciences, USA, 94, 10687.
21. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.M., Wright W.E., Wewrich S.L., Shay J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011.
22. Kondo S., Tanaka Y., Kondo Y., Hitomi M., Barnett G.H., Ishizaka Y., Liu J., Haqqi T., Nishiyama A., Villeponteau B., Cowell J.K., Barna B.P. (1998a) Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB Journal, 12, 801.
23. Kondo S., Kondo Y., Li G., Silverman R.H., Cowell J.K. (1998b) Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene, 16, 3323.
24. Kuroki T., Huh N.-H. (1993) Why are human cells resistant to malignant cell transformation in vitro? Japanese Journal of Cancer Research, 84, 1091.
25. Makarov V.L., Hirose Y., Langmore J.P. (1997) Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell, 88, 657.
26. Morin G.B. (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59, 521.
27. Naasani I., Seimiya H., Tsuruo T. (1998) Telomerase inhibition, telomere shortening, senescence of cancer cells by tea catechins. Biochemical and Biophysical Research Communications, 249, 391.
28. Nelson W.G., Kastan M.B. (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Molecular and Cellular Biology, 14, 1815.
29. Olovnikov A.M. (1971) Principle of marginotomii in the template synthesis of polynucleotides. Doklady Akademii Nauk SSSR, 201, 1496.
30. Ookawa K., Tsuchlda S., Adachi J.-I., Yokota J. (1997) Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line. Oncogene, 14, 1389.
31. Pai R.B., Pai B., Kukhanova M., Dutschman G.E., Guo, X., Cheng Y.-C. (1998) Telomerase from human leukemia cells: properties and its interaction with deoxynucleoside analogues. Cancer Research, 58, 1909.
32. Prudovsky I.A., Yegorov Y.E., Zelenin A.V. (1985) DNA synthesis in the heterokarions of nondividing differentiated cells and culture cells with various proliferative potentials. Cell Differentiation, 17, 239.
33. Rubelj I., Pereira-Smith O.M. (1994) SV40-transformed human cells in crisis exhibit changes that occur in normal cellular senescence. Experimental Cell Research, 211, 82.
34. Shay J.W., Wright W.F., Werbin H. (1991a) Defining the molecular mechanisms of human cell immortalization. Biochimica et Biophysica Acta, 1072, 1.
35. Shay J.W., Pereira-Smith O.M., Wright W.E. (1991b) A role for both RB and p53 in the regulation of human cellular senescence. Experimental Cell Research, 196, 33.
36. Shay J.W., Wright W.E., Brasiskyte D., van der Haegen B.A. (1993a) E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene, 8, 1407.
37. Shay J.W., van der Haegen B.A., Ying Y., Wright W.E. (1993b) The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Experimental Cell Research, 209, 45.
38. Shay J.W., Wright W.E. (1996) The reactivation of telomerase activity in cancer progression. Trends in Genetics, 12, 129.
39. Strahl C., Blackburn E.H. (1994) The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucleic Acids Research, 22, 893.
40. Strahl C., Blackburn E.H. (1996) Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortal human cell lines. Molecular and Cellular Biology, 16, 53.
41. Vaziri H., West M.D., Allsopp R.C., Davison T.S., Wu Y.S., Arrowsmith C.H., Poirier G.G., Benchimol S. (1997) AIM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO Journal, 16, 6018.
42. Watson J.D. (1972) Origin of concatemeric T7 DNA. Nature, 239, 197.
43. Wellinger, R.J., Ethier K., Labrecque P., Zakian V.A. (1996) Evidence for a new step in telomere maintenance. Cell, 85, 423.
44. Wright W.E., Pereira-Smith O.M., Shay J.W. (1989) Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Molecular and Cellular Biology, 9, 3088.
45. Wright W.E., Shay J.W. (1992) The two-stage mechanism controlling cellular senescence and immortalization. Experimental Gerontology, 27, 383.
46. Wright W.E., Shay J.W. (1996) Mechanisms of escaping senescence in human diploid cells. In Cellular Aging and Cell Death. Wiley-Liss, p. 153.
47. Wright W.E., Tesmer V.M., Huffman K.E., Levene S.D., Shay J.W. (1997) Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes and Development, 11, 2801.
48. Yegorov Y.E., Chernov D.N., Akimov S.S., Bolsheva N.L., Krayevsky A.A., Zelenin A.V. (1996) Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts. FEBS Letters, 389, 115.
49. Yegorov Y.E., Chernov D.N., Akimov S.S., Bol'sheva N.L., Kraevsky A.A., Zelenin A.V. (1997a) Effect of reverse transcriptase inhibitors on telomerase function in immortal mouse fibroblasts. Molecular Biology (Moscow), 31, 108.
50. Yegorov Y.E., Chernov D.N., Akimov S.S., Akhmalisheva A.K., Smirnova Y.B., Shinkarev D.B., Semenova I.V., Yegorova, I.N., Zelenin A.V. (1997b) Blockade of telomerase function by nucleoside analogs. Biochemistry (Moscow), 62, 1296.
51. Yegorov Y.E., Akhmalisheva A.K., Smirnova Y.B., Shinkarev D.B., Chernov D.N., Zelenin A.V., Kraevskii A.A. (1997c) Azidothymidine, blocking telomerase functioning, shortens telomeric repeats in transformed human cells. Russian Journal of Genetics, 33, 1238.
52. Yegorov Y.E., Akimov S.S., Hass R., Zelenin A.V., Prudovsky, I.A. (1998) Endogenous beta-galactosidase activity in continuously nonproliferating cells. Experimental Cell Research, 243, 207.
53. Yegorov Y.E., Chernov D.N., Akimov S.S., Akhmalisheva A.K., Popov K.V., Hass R., Prudovsky I.A., Zelenin A.V. (1999) Telomerase activity of the cells during alteration of their proliferative states. Membrane and Cell Biology, 12, 793.
54. Zaitseva V.E., Dyatkina N.B., Krayevsky A.A., Skaptsova N.V., Turina O.V., Gnuchev N.V., Gottikh B.P., Azhaev A.V. (1984) Aminonucleosides and their derivatives. XI. Synthesis of 3′-amino-2′,3′-dideoxynucleoside 5′-triphosphates. Bioorganic Chemistry (Moscow), 10, 670.
55. Zakian V.A. (1989) Structure and function of telomeres. Annual Review of Genetics, 23, 579.